Theme: Epidemiology & Public Health Research Year: 2024
Background: Hepatitis C virus (HCV) infection poses a significant health challenge, particularly among people who use drugs (PWUD). This study aims to demonstrate the effectiveness of a unique HCV outreach program partnership with organizations serving at risk communities to increase HCV testing and linkage to Direct-Acting Antiviral (DAA) treatment (Viral Elimination (VEN) Centers).
Methods: From January 1, 2024, to June 30, 2024, VEN Centers conducted HCV testing outreach events throughout Arizona in collaboration with prison re-entry programs, recovery centers, unsheltered community service programs, syringe service programs, and medication-assisted treatment (MAT) facilities. Individuals engaging in the services of community agencies were simultaneously offered HCV screening by VEN; with point-of-care (POC) testing, confirmation phlebotomy, and telehealth visits occurring during the same visit. Persons presenting with known (self-reported and confirmed HCV Ab+) were also linked to DAA treatment utilizing the same treatment model.
Results: In only six months, 256 people with HCV were linked to care. Of these 174 (68.0%) patients had known HCV and 91 (32.0%) unknown/new HCV Ab+ cases (8.8% overall HCVAb+ 8.83%). By patient intake site: 45 known HCVAb+ and 35 new HCV Ab+ from harm reduction (13.16% HCVAb+); 47 known and 3 new HCVAb+ cases from MAT (4.48% HCVAb+); 42 known and 23 new HCVAb+ cases from recovery (9.83% HCV Ab+); 20 known and 20 new HCV Ab+ cases from houseless services (7.41% HCVAb+). 20 known and 10 new HCV Ab+ cases from prison re-entry (5.15% HCVAb+).
Conclusion: By integrating comprehensive HCV services with community agencies, VEN Centers effectively streamlined care coordination and improved linkage to DAA treatment. HCV Ab + (4.5-13.63%) varied by patient source but remained above national average. The majority of patients treated (68%) were aware they had HCV but had never been treated. Collaboration with local agencies who support at risk communities effectively bridges barriers to HCV healthcare.
Download abstract Download poster